-+ 0.00%
-+ 0.00%
-+ 0.00%

Niagen Bioscience Raises FY2026 Sales Guidance from $138.982M-$145.299M to $145.299M-$151.616M vs $130.410M Est

Benzinga·11/04/2026 21:21:48
Listen to the news
Niagen Bioscience (NASDAQ:NAGE) raises FY2026 sales outlook from $138.982 million-$145.299 million to $145.299 million-$151.616 million vs $130.410 million estimate.